title: Gemcitabine and acute myocardial infarction--a case report.
abstract: The objective of this paper is to report a case of acute, non-q-wave myocardial infarction, presumably secondary to gemcitabine chemotherapy for nonsmall cell lung cancer. A 43-year-old woman with postpartum cardiomyopathy and ischemic heart disease was treated with gemcitabine for metastatic nonsmall cell lung cancer. Three days after her 5th treatment with gemcitabine, she developed chest pain and was diagnosed as having acute, non-q-wave myocardial infarction. She made an uneventful recovery. An objective causality assessment revealed that the adverse event was possible. Gemcitabine has been previously reported to be causative of acute myocardial infarction. Ischemic complications of chemotherapeutic agents are discussed. A review of literature on this subject is presented. Gemcitabine should be administered with caution in patients with underlying cardiac disease.
authors.affiliation: State University of New York at Buffalo, Buffalo, NY.
authors.forename: Fadi M
authors.initials: FM
authors.lastname: Bdair
authors.forename: Susan P
authors.initials: SP
authors.lastname: Graham
authors.forename: Patrick F
authors.initials: PF
authors.lastname: Smith
authors.forename: Milind M
authors.initials: MM
authors.lastname: Javle
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D004562:Electrocardiography; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000188:drug therapy; D009362:Neoplasm Metastasis; D011799:Quinazolines / Q000627:therapeutic use; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D011799:Quinazolines; D003841:Deoxycytidine; D000077156:Gefitinib; D000093542:Gemcitabine